UK markets close in 6 hours 56 minutes

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,085.40+15.40 (+1.44%)
As of 02:44PM IST. Market open.
Currency in INR

Valuation measures4

Market cap (intra-day) 627.16B
Enterprise value 619.28B
Trailing P/E 22.65
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.27
Price/book (mrq)2.22
Enterprise value/revenue 2.24
Enterprise value/EBITDA 10.99

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3106.56%
S&P500 52-week change 329.57%
52-week high 31,177.00
52-week low 3510.85
50-day moving average 31,058.17
200-day moving average 3921.50

Share statistics

Avg vol (3-month) 3146.36k
Avg vol (10-day) 330.67k
Shares outstanding 5585.94M
Implied shares outstanding 6586.13M
Float 8279.81M
% held by insiders 152.06%
% held by institutions 129.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 44.5
Forward annual dividend yield 40.42%
Trailing annual dividend rate 34.50
Trailing annual dividend yield 30.42%
5-year average dividend yield 40.69
Payout ratio 412.70%
Dividend date 3N/A
Ex-dividend date 420 Feb 2024
Last split factor 22:1
Last split date 320 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.93%
Operating margin (ttm)16.02%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)278.95B
Revenue per share (ttm)475.61
Quarterly revenue growth (yoy)14.70%
Gross profit (ttm)N/A
EBITDA 48.94B
Net income avi to common (ttm)27.7B
Diluted EPS (ttm)47.19
Quarterly earnings growth (yoy)90.60%

Balance sheet

Total cash (mrq)71.49B
Total cash per share (mrq)122.47
Total debt (mrq)66.49B
Total debt/equity (mrq)23.58%
Current ratio (mrq)N/A
Book value per share (mrq)477.64

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A